alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# L_2012161EN.01002501.xml

| 21.6.2012 | EN | Official Journal of the European Union | L 161/25 |
| --- | --- | --- | --- |

21.6.2012

EN

Official Journal of the European Union

L 161/25

---

DECISION OF THE EEA JOINT COMMITTEE

No 19/2012

of 10 February 2012

amending Annex IX (Financial services) to the EEA Agreement

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area, as amended by the Protocol adjusting the Agreement on the European Economic Area, hereinafter referred to as ‘the Agreement’, and in particular Article 98 thereof,

Whereas:

| (1) | Annex IX to the Agreement was amended by Decision of the EEA Joint Committee No 117/2011 of 21 October 2011 (1). |
| --- | --- |

(1)

Annex IX to the Agreement was amended by Decision of the EEA Joint Committee No 117/2011 of 21 October 2011 (1).

| (2) | Directive 2010/76/EU of the European Parliament and of the Council of 24 November 2010 amending Directives 2006/48/EC and 2006/49/EC as regards capital requirements for the trading book and for re-securitisations, and the supervisory review of remuneration policies (2) is to be incorporated into the Agreement, |
| --- | --- |

(2)

Directive 2010/76/EU of the European Parliament and of the Council of 24 November 2010 amending Directives 2006/48/EC and 2006/49/EC as regards capital requirements for the trading book and for re-securitisations, and the supervisory review of remuneration policies (2) is to be incorporated into the Agreement,

HAS ADOPTED THIS DECISION:

Article 1

The following indent shall be added in points 14 (Directive 2006/48/EC of the European Parliament and of the Council) and 31 (Directive 2006/49/EC of the European Parliament and of the Council) of Annex IX to the Agreement:

| ‘— | 32010 L 0076: Directive 2010/76/EU of the European Parliament and of the Council of 24 November 2010 (OJ L 329, 14.12.2010, p. 3).’. |
| --- | --- |

‘—

32010 L 0076: Directive 2010/76/EU of the European Parliament and of the Council of 24 November 2010 (OJ L 329, 14.12.2010, p. 3).’.

Article 2

The text of Directive 2010/76/EU in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 11 February 2012, provided that all the notifications under Article 103(1) of the Agreement have been made to the EEA Joint Committee (*1).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 10 February 2012.

For the EEA Joint Committee

The Acting President

Gianluca GRIPPA

---

(1)  
  OJ L 341, 22.12.2011, p. 81.

1

(2)  
  OJ L 329, 14.12.2010, p. 3.

2

(*1)  Constitutional requirements indicated.

*1

---
Daniel D. STAHL, petitioner, v. NEW YORK.

No. 17-78.

Supreme Court of the United States

Oct. 2, 2017.

Petition for writ of certiorari to the Appellate Division, Supreme Court of New York, Third Judicial Department denied.
Edgar CARRILLO, petitioner, v. Michael SEXTON, Warden.

No. 17-8295.

Supreme Court of the United States

June 4, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
---

Exhibit 99.15



CONSENT OF PINCOCK, ALLEN & Holt

We hereby consent to the use of our name in connection with the following report and documents, which are being filed as exhibits to and incorporated by reference into the registration statement on Form 40-F of Gammon Gold Inc. (the
Company) being filed with the United States Securities and Exchange Commission:

1.

The technical report dated November 25, 2002 entitled Guadalupe y Calvo Gold-Silver Project, Chihuahua, Mexico, (the Guadalupe Report);

2.

Information relating to the mineral reserve and mineral resource calculations for the Guadalupe y Calvo Gold-Silver Project; and

3.

The Annual Information Form of the Company dated March 30, 2010, which includes
reference to my name in connection with information relating to the Guadalupe
Report, and the properties described therein.

Date: March 30, 2010

Sincerely,

/s/ Barton G. Stone
BARTONG.STONE,C.P.G.Chief Geologist, Pincock, Allen & Holt, Inc.

---
# L_2011171EN.01004201.xml

| 30.6.2011 | EN | Official Journal of the European Union | L 171/42 |
| --- | --- | --- | --- |

30.6.2011

EN

Official Journal of the European Union

L 171/42

---

DECISION OF THE EEA JOINT COMMITTEE

No 41/2011

of 1 April 2011

amending Annex XVIII (Health and safety at work, labour law, and equal treatment for men and women) to the EEA Agreement

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area, as amended by the Protocol adjusting the Agreement on the European Economic Area, hereinafter referred to as ‘the Agreement’, and in particular Article 98 thereof,

Whereas:

| (1) | Annex XVIII to the Agreement was amended by Decision of the EEA Joint Committee No 141/2010 of 10 December 2010 (1). |
| --- | --- |

(1)

Annex XVIII to the Agreement was amended by Decision of the EEA Joint Committee No 141/2010 of 10 December 2010 (1).

| (2) | Council Directive 2010/32/EU of 10 May 2010 implementing the Framework Agreement on prevention from sharp injuries in the hospital and healthcare sector concluded by HOSPEEM and EPSU (2) is to be incorporated into the Agreement, |
| --- | --- |

(2)

Council Directive 2010/32/EU of 10 May 2010 implementing the Framework Agreement on prevention from sharp injuries in the hospital and healthcare sector concluded by HOSPEEM and EPSU (2) is to be incorporated into the Agreement,

HAS DECIDED AS FOLLOWS:

Article 1

The following point shall be inserted after point 16jf (Commission Directive 2009/161/EU) of Annex XVIII to the Agreement:

| ‘16jg. | 32010 L 0032: Council Directive 2010/32/EU of 10 May 2010 implementing the Framework Agreement on prevention from sharp injuries in the hospital and healthcare sector concluded by HOSPEEM and EPSU (OJ L 134, 1.6.2010, p. 66).’. |
| --- | --- |

‘16jg.

32010 L 0032: Council Directive 2010/32/EU of 10 May 2010 implementing the Framework Agreement on prevention from sharp injuries in the hospital and healthcare sector concluded by HOSPEEM and EPSU (OJ L 134, 1.6.2010, p. 66).’.

Article 2

The text of Directive 2010/32/EU in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 2 April 2011, provided that all the notifications under Article 103(1) of the Agreement have been made to the EEA Joint Committee (*1).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 1 April 2011.

For the EEA Joint Committee

The Acting President

Gianluca GRIPPA

---

(1)  
  OJ L 85, 31.3.2011, p. 26.

1

(2)  
  OJ L 134, 1.6.2010, p. 66.

2

(*1)  No constitutional requirements indicated.

*1

---
Created with Sketch.Menu Transparency
	Contact Us Search
Search
 Main navigation

      
      About the CFTC
                          The Commission
                        Chairman & Commissioners
                        CFTC Organization
                        Advisory Committees
                        Budget & Performance
                        Privacy at the CFTC
                        Careers
                        Diversity and Inclusion at the CFTC
                        Industry Oversight
                          Industry Filings
                        Trading Organizations
                        Clearing Organizations
                        Data Repositories
                        Intermediaries
                        Market Surveillance
                        Contracts & Products
                        Rules & Rule Amendments
                        Anti-Money Laundering
                        Law & Regulation
                          Commodity Exchange Act & Regulations
                        How Rules Are Made
                        Holding Wrongdoers Accountable
                        Federal Register
                        Public Comments
                        CFTC Staff Letters
                        Office of Technology Innovation
                        Market Data & Economic Analysis
                          Data at CFTC
                        Commitments of Traders
                        Bank Participation Reports
                        Cotton On-Call
                        Financial Data for FCMS
                        Net Position Changes Data
                        Staff Reports
                        Weekly Swaps Report
                        Cleared Margin Reports
                        Office of the Chief Economist
                        Forms & Submissions
                        Learn & Protect
                          Check Registration & Disciplinary History
                        Submit a Tip
                        Reparations Program
                        RED List
                        Advisories & Articles
                        Videos
                        Publications
                        News & Events
                          Press Releases
                        Public Statements & Remarks
                        Events Carousel Rotation On
              On


External Meetings: SEFs
  
    



  Topic: swaps made avaialble for trading
      
  When
              09/22/2011

  Rulemaking(s)
              XIII. SEF Registration

  CFTC Staff
              Megan Sperling

  Visitor(s)
              Pat McCarty, ICAP

  Organization(s)
              ICAP


Resources

CFTC Regulations
	Commodity Exchange Act
	Privacy Policy
	Web Policy
	FOIA
	EEO Statement
	No Fear Act
	Accessibility Statement
	Procurement
	USA.gov
	Glossary

Actions

Search Public Comments
	Submit Tips & Complaints
	Search Industry FilingsWhistleblower.gov
	Office of Technology InnovationInspector GeneralSitemap

HomeCFTC Headquarters
Three Lafayette Centre
1155 21st Street, NW
Washington, DC 20581
202.418.5000
Selomi M. VILLALTA, petitioner, v. EXECUTIVE OFFICE FOR IMMIGRATION REVIEW, et al.

No. 16-8601.

Supreme Court of the United States

July 17, 2017.

Petition for rehearing denied.
Exhibit 10.1(d)

Form 10-K for the Fiscal Year Ended November 30, 2006

SUMMARY OF DIRECTOR COMPENSATION

Hooker Furniture Corporation

For calendar year 2007, non-employee directors will receive the following cash compensation:



| |  |  | $18,000 annual retainer for service on the Board; plus
| | - |  | ------------------------------------------------------



| |  |  | $7,500 for serving on the Audit Committee and $3,000 for serving on each of the Compensation and Nominating and Corporate Governance Committees;
| | - |  | ------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | an additional $4,500 for the Chair of the Audit Committee; and
| | - |  | --------------------------------------------------------------



| |  |  | an additional $3,000 for the Chairs of the Compensation and Nominating and Corporate Governance Committees.
| | - |  | -----------------------------------------------------------------------------------------------------------

In addition, directors are reimbursed for reasonable expenses incurred in connection with attending board and committee meetings or performing their
duties as directors.

In 2006, non-employee directors began receiving an annual grant of restricted stock under the Companys 2005
Stock Incentive Plan. The plan was approved by shareholders at the 2005 Annual Meeting. The number of shares of restricted stock awarded to each non-employee director is determined by dividing fifty percent of the total annual fees payable to that
director by the fair market value of the Companys Common Stock on the award date (the average of the high and low market price of the stock on the day prior to the grant date), and rounding to the nearest whole share. The restricted stock will
become fully vested, and the restrictions applicable to the restricted stock will lapse, on the third anniversary of the grant date, or if earlier, when the director dies or is disabled, the Annual Shareholders Meeting following the directors
attainment of age 75, or a change in control of the Company.

On January 15, 2007, each non-employee director of the Company received
an award of restricted shares of Company Common Stock as set forth in the table below:



|                           |  |                                    
|-------------------------- |  | -----------------------------------
|Outside Director           |  | RestrictedStock Grant (# of shares)
|W. Christopher Beeler, Jr. |  | 1,034                              
|John L. Gregory, III       |  | 886                                
|Mark F. Schreiber          |  | 936                                
|David G. Sweet             |  | 936                                
|Henry G. Williamson, Jr.   |  | 1,083
Girish SAHU, petitioner, v. MINNEAPOLIS COMMUNITY AND TECHNICAL COLLEGE, et al.

No. 17-5048.

Supreme Court of the United States

Oct. 2, 2017.

Petition for writ of certiorari to the United States Court of Appeals for the Eighth Circuit denied.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Food and Drug Administration

          - [Docket No. FDA-2022-N-0030]

# AGENCY:

Food and Drug Administration, HHS.

# ACTION:

Notice; correction.

# SUMMARY:

                        The Food and Drug Administration (FDA) is correcting a notice that appeared in the                         **Federal Register**                         on February 28, 2022. The document announced the withdrawal of approval of five abbreviated new drug applications (ANDAs) from multiple applicants as of March 30, 2022. The document indicated that FDA was withdrawing approval of the following ANDA after receiving a withdrawal request from Jiangsu Hengrui Pharmaceuticals Co., Ltd., U.S. Agent, Venus Pharmaceutical Laboratories Inc., 506 Carnegie Center, Suite 100, Princeton, NJ 08540: ANDA 091008, Gabapentin Capsules, 100 milligrams (mg), 300 mg, and 400 mg. Before FDA withdrew the approval of this ANDA, Jiangsu Hengrui Pharmaceuticals Co., Ltd., informed FDA that it did not want the approval of the ANDA withdrawn. Because Jiangsu Hengrui Pharmaceuticals Co., Ltd., timely requested that approval of this ANDA not be withdrawn, the approval of ANDA 091008 is still in effect.                    

# FOR FURTHER INFORMATION CONTACT:

                        Martha Nguyen, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 75, Rm. 1676, Silver Spring, MD 20993-0002, 240-402-6980,                         *Martha.Nguyen@fda.hhs.gov.*

# SUPPLEMENTARY INFORMATION:

                    In the                     **Federal Register**                     of February 28, 2022 (87 FR 11079), appearing on page 11079 in FR Doc. 2022-04153, the following correction is made:                

On page 11079, in the table, the entry for ANDA 091008 is removed.

Dated: April 13, 2022.

Lauren K. Roth,

Associate Commissioner for Policy.

[FR Doc. 2022-08299 Filed 4-18-22; 8:45 am]

BILLING CODE 4164-01-P
<PAGE>
                                                                    Exhibit 32.1

                  CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350

      In connection with the accompanying Quarterly Report of Laserscope on Form
10-Q for the nine months ended September 30, 2003, I, Eric M. Reuter, President
and Chief Executive Officer of Laserscope, hereby certify pursuant to 18 U.S.C.
section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of
2002, that:

      (1)   such Quarterly Report on Form 10-Q for the nine months ended
            September 30, 2003 fully complies with the requirements of section
            13(a) or 15(d) of the Securities Exchange Act of 1934; and

      (2)   the information contained in such Quarterly Report on Form 10-Q for
            the nine months ended September 30, 2003 fairly presents, in all
            material respects, the financial condition and results of operations
            of Laserscope.



Date:  November 13, 2003                By:    /s/  Eric M. Reuter
                                           ------------------------------------
                                           Eric M. Reuter
                                           President and Chief Executive Officer

A signed original of this written statement required by section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the electronic version of this written statement
required by section 906, has been provided to Laserscope and will be retained by
Laserscope and furnished to the Securities and Exchange Commission or its staff
upon request.
#### City of Miami, a municipal corporation, Plaintiff in Error, v. J. E. Rose & Company, a corporation, *Defendant in Error.*

Division B.

Decision filed January 31, 1929.

*John W. Watson, Jr.*and *Chas E. Davis,*for Plaintiff in in Error;

*Twyman & McCarthy*and *Robert II. Anderson,*for Defendant in Error.

Per Curiam.

This cause having heretofore been submitted to the Court upon the transcript of the record of the judgment herein, and briefs and argument of counsel for the respective parties, and the record having been seen and inspected, and the Court being now advised of its judgment to be given in the premises, it seems to the Court that there is no error in the said judgment; it is, therefore, con*126sidered, ordered and adjudged by tbe Court that the said judgment of the circuit court be, and the same is hereby affirmed.

Whitfield, P. J., and Strum and Buford, J. J., concur.
Andre COOPER, petitioner, v. UNITED STATES.

No. 17-6084.

Supreme Court of the United States

Oct. 30, 2017.

Petition for writ of certiorari to the United States Court of Appeals for the Third Circuit denied.

Justice KAGAN took no part in the consideration or decision of this petition.
## FILED U.S. COURT OF APPEALS ELEVENTH CIRCUIT 12/31/98 THOMAS K. KAHN CLERK [PUBLISH]

IN THE UNITED STATES COURT OF APPEALS
FOR THE ELEVENTH CIRCUIT

No. 97-8415 D. C. Docket No. 1:92-cv-103-JEC

ALEJANDRO ESCARENO, Plaintiff-Appellant,

versus NOLTINA CRUCIBLE AND REFRACTORY CORPORATION, et al., Defendants, CARL NOLTE SOHNE GMBH, Defendant-Appellee.

Appeal from the United States District Court for the Northern District of Georgia (December 31, 1998)
Before COX, DUBINA and BLACK, Circuit Judges.
PER CURIAM:2 The issue in this case is whether the Fulton County, Georgia, Probate Court properly appointed an administrator over the estate of Alejandro Escareno (“Escareno” or “Plaintiff”), the deceased Plaintiff in this products liability suit. The Plaintiff contends that pursuant to O.C.G.A. § 15-9-31 the Georgia Probate Court acted within its jurisdiction when it appointed Philip P. Grant (“Grant”) as administrator of Escareno’s esta te. The district court denied the Plaintiff’s motion to substitute Grant as a party pursuant to Fed.R.Civ.P. 25(a) on the ground that the probate court lacked jurisdiction to appoint an administrator because Escareno, a Mexican resident, did not have any property in Fulton Count y, nor did he have a cause of action against a Fulton County defendant. See O.C.G.A. § 15-9-31. To decide this case, we are required to determine the precise requirements of § 15-9-31 for the administration of the estate of a non-resident of Georgia. Because this statute allows for differing interpretations and there are no controlling precedents under Georgia law, we certified the following question to the Supreme Court of Georgia: Whether the appointment of Grant as administrator of Escareno’s estate was proper under § 15-9-31(2) based upon either the pending cause of action in Fulton County against a foreign defendant or the presence of a case file in Escareno’s counsel’s office. On November 23, 1998, the Supreme Court of Georgia issued an opinion answering our question in the affirmative. In light of the Supreme Court of Georgia’s opinion, attached hereto as an appendix, we vacate the district court’s order denying Escareno’s motion to substitute Grant as administrator of Escareno’s estate, and the district court’s order of dismissal, and remand this case for further proceedings consistent with the opinion of the Supreme Court of Georgia.3 VACATED and REMANDED.
HELSINN HEALTHCARE S.A., petitioner, v. TEVA PHARMACEUTICALS USA, INC., et al.

No. 17-1229.

Supreme Court of the United States

June 25, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit granted.